Your browser doesn't support javascript.
loading
Cyclin-dependent kinase 9 as a potential specific molecular target in NK-cell leukemia/lymphoma.
Kinoshita, Shiori; Ishida, Takashi; Ito, Asahi; Narita, Tomoko; Masaki, Ayako; Suzuki, Susumu; Yoshida, Takashi; Ri, Masaki; Kusumoto, Shigeru; Komatsu, Hirokazu; Shimizu, Norio; Inagaki, Hiroshi; Kuroda, Taruho; Scholz, Arne; Ueda, Ryuzo; Sanda, Takaomi; Iida, Shinsuke.
Affiliation
  • Kinoshita S; Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Japan.
  • Ishida T; Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Japan itakashi@iwate-med.ac.jp.
  • Ito A; Division of Hematology and Oncology, Department of Internal Medicine, School of Medicine, Iwate Medical University, Japan.
  • Narita T; Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Japan.
  • Masaki A; Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Japan.
  • Suzuki S; Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Japan.
  • Yoshida T; Department of Pathology and Molecular Diagnostics, Nagoya City University Graduate School of Medical Sciences, Japan.
  • Ri M; Department of Tumor Immunology, Aichi Medical University School of Medicine, Japan.
  • Kusumoto S; Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Japan.
  • Komatsu H; Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Japan.
  • Shimizu N; Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Japan.
  • Inagaki H; Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Japan.
  • Kuroda T; Department of Virology, Division of Medical Science, Medical Research Institute, Tokyo Medical and Dental University, Japan.
  • Scholz A; Department of Pathology and Molecular Diagnostics, Nagoya City University Graduate School of Medical Sciences, Japan.
  • Ueda R; Bayer Yakuhin, Ltd., Osaka, Japan.
  • Sanda T; Bayer AG Pharmaceuticals Division, Berlin, Germany.
  • Iida S; Department of Tumor Immunology, Aichi Medical University School of Medicine, Japan.
Haematologica ; 103(12): 2059-2068, 2018 12.
Article in En | MEDLINE | ID: mdl-30076184
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sulfonamides / Triazines / Killer Cells, Natural / Leukemia / Xenograft Model Antitumor Assays / Cyclin-Dependent Kinase 9 / Lymphoma Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Haematologica Year: 2018 Type: Article Affiliation country: Japan
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sulfonamides / Triazines / Killer Cells, Natural / Leukemia / Xenograft Model Antitumor Assays / Cyclin-Dependent Kinase 9 / Lymphoma Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Haematologica Year: 2018 Type: Article Affiliation country: Japan